ArticleScientific reports2026
Impact of changes in sarcopenia status on incident cardiovascular disease and mortality in older adults.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Sarcopenia is an independent risk factor for cardiovascular disease (CVD) and mortality. However, the impact of longitudinal changes in sarcopenia remains unclear. We investigated the relationship between changes in sarcopenia status and the risk of CVD and mortality in older Korean adults. This study included 2,997 older adults aged ≥ 65 years from the Korea Urban and Rural Elderly Study. Sarcopenia status was classified as non-sarcopenia, possible sarcopenia, or functional sarcopenia. Changes in sarcopenia status were assessed at baseline and during a follow-up visit 4 years later. Incident CVD was defined as hospitalization for ischemic heart disease or cerebrovascular disease. All-cause mortality was determined using death records provided by Statistics Korea. Associations were evaluated using Cox proportional hazards regression models. During the follow-up, a total of 423 incident CVD cases and 438 deaths were identified. At baseline, individuals with functional sarcopenia had a higher risk of incident CVD and mortality than those without, after adjusting for all covariates. Similarly, participants who progressed from non-sarcopenia to sarcopenia or had stable sarcopenia showed increased CVD and mortality risk. Sarcopenia was associated with elevated risks of CVD and mortality. Early identification and management of sarcopenia may help reduce adverse outcomes in older adults.
Indexed as
Identifiers
42463760What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.